D Medical insulin kits listed in Diabetes Consumer Guide

The American Diabetes Association cited Spring Universal Infusion Set in the'New and Notable' section of its Consumer Guide.

D Medical Industries Ltd. (Nasdaq: DMED); TASE:DMED) today announced that its Spring Universal Infusion Set insulin pump has been listed in the American Diabetes Association 2012 Consumer Guide, published by the Diabetes Forecast Magazine.

D Medical CEO Efri Argaman said, "We are pleased that, as we are expanding our US distribution network, our diabetes product is gaining market acceptance, evidenced by being listed in the 'New and Notable' section of the industry’s most prominent diabetes association consumer guide."

Last month D Medical subsidiary Spring Health Solutions, which makes the insulin pump, signed a US distribution agreement with Agile Edge Technologies Inc. D Medical estimates the US market for infusion sets at $730 million a year. It said that 350,000 diabetics in the US use insulin pumps out of the 26 million diabetics in the country, 1.4 million of whom have type 1 diabetes.

D Medical's share price rose 5.7% in morning trading on the TASE today, following the announcement, to NIS 5.43, after falling 6.5% on Nasdaq yesterday to $1.44, giving a market cap of $12 million.

Published by Globes [online], Israel business news - www.globes-online.com - on January 4, 2012

© Copyright of Globes Publisher Itonut (1983) Ltd. 2012

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018